LDR Capital Management LLC Invests $500,000 in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)

LDR Capital Management LLC bought a new position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 28,625 shares of the real estate investment trust's stock, valued at approximately $500,000. Sabra Healthcare REIT accounts for about 0.6% of LDR Capital Management LLC's investment portfolio, making the stock its 27th largest holding.

A number of other institutional investors also recently bought and sold shares of SBRA. VSM Wealth Advisory LLC acquired a new stake in shares of Sabra Healthcare REIT during the fourth quarter valued at about $26,000. UMB Bank n.a. grew its holdings in shares of Sabra Healthcare REIT by 379.6% in the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock valued at $36,000 after purchasing an additional 1,621 shares in the last quarter. Assetmark Inc. grew its holdings in shares of Sabra Healthcare REIT by 33.4% in the fourth quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust's stock valued at $45,000 after purchasing an additional 656 shares in the last quarter. Fifth Third Bancorp lifted its stake in Sabra Healthcare REIT by 110.3% in the first quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust's stock worth $67,000 after acquiring an additional 2,011 shares during the last quarter. Finally, GF Fund Management CO. LTD. purchased a new position in Sabra Healthcare REIT in the fourth quarter worth approximately $74,000. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Stock Performance

SBRA stock traded down $0.03 on Friday, hitting $18.25. The company's stock had a trading volume of 3,343,753 shares, compared to its average volume of 2,288,680. The firm has a 50 day moving average of $17.79 and a two-hundred day moving average of $17.26. Sabra Healthcare REIT, Inc. has a 1 year low of $14.63 and a 1 year high of $20.03. The stock has a market cap of $4.34 billion, a price-to-earnings ratio of 30.93, a price-to-earnings-growth ratio of 1.38 and a beta of 0.85. The company has a current ratio of 4.22, a quick ratio of 4.22 and a debt-to-equity ratio of 0.89.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $0.37 EPS for the quarter, beating the consensus estimate of $0.36 by $0.01. The firm had revenue of $183.54 million during the quarter, compared to the consensus estimate of $180.23 million. Sabra Healthcare REIT had a net margin of 19.55% and a return on equity of 5.14%. Sabra Healthcare REIT's revenue for the quarter was up 10.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.35 EPS. Equities analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Friday, May 16th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, May 16th. This represents a $1.20 annualized dividend and a yield of 6.58%. Sabra Healthcare REIT's dividend payout ratio is currently 203.39%.

Analyst Ratings Changes

Several analysts have recently weighed in on SBRA shares. Scotiabank boosted their price objective on shares of Sabra Healthcare REIT from $18.00 to $19.00 and gave the stock a "sector perform" rating in a research report on Monday, May 12th. Truist Financial boosted their price objective on shares of Sabra Healthcare REIT from $17.00 to $18.00 and gave the stock a "hold" rating in a research report on Tuesday, March 18th. Three investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $19.50.

Insider Buying and Selling at Sabra Healthcare REIT

In other Sabra Healthcare REIT news, Director Michael J. Foster sold 11,000 shares of the business's stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the transaction, the director now directly owns 64,725 shares of the company's stock, valued at approximately $1,179,289.50. The trade was a 14.53% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.20% of the stock is currently owned by corporate insiders.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.